A study of 6,388 cases and 4,995 controls from the Breast Cancer Association Consortium (BCAC) and 5,617 BRCA1 and BRCA2 carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) concluded that there is no evidence that rs570613 is associated with breast cancer risk in women.[PMID 19082709]
[PMID 18006915] Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
[PMID 18410415] Polymorphisms in the interleukin 13 and GATA binding protein 3 genes and the development of eczema during childhood.
[PMID 18505952] Genetic susceptibility to cancer: the role of polymorphisms in candidate genes.